Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that the Company will participate in t ...

Dynavax Technologies (NASDAQ:DVAX – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Monday. A number ...

MURFREESBORO, TN / ACCESS Newswire / February 25, 2025 / National Health Investors, Inc. announced today that it will pay its first quarter dividend of $0.90 per common share on May 2, 2025 to ...

The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, ...

The pharma group has just announced that it will build four new manufacturing facilities in the US – at a cost of around $27 ...